Workshop 3: Advancing Rational Drug Treatment: Integrating People, Computerized Decision Support and Artificial Intelligence
Tracks
Track 1
| Sunday, July 12, 2026 |
| 11:15 AM - 1:15 PM |
Details
The workshop "Advancing Rational Drug Treatment: Integrating People, Computerized Decision Support and Artificial Intelligence" aims to explore cutting-edge innovations in the use of technology for enhancing drug therapy management, as well as human factors. With the rapid advancements in artificial intelligence (AI) and computerized decision support systems (CDSS), healthcare professionals are equipped with potentially powerful tools to optimize medication use, improve patient outcomes, and reduce adverse drug events. This workshop will bring together esteemed speakers from around the globe, each of whom is a pioneer in their respective fields of computerized decision support for rational drug treatment. The agenda includes short keynote presentations that highlight recent research breakthroughs, practical applications, and case studies demonstrating successful implementation of these technologies. A dynamic panel discussion will provide an interactive platform for experts to debate the future directions and ethical considerations of AI in drug treatment. Attendees will have the opportunity to engage with the speakers during a Q&A session and network with peers to foster collaboration and innovation. By bridging the gap between technological advancements and clinical practice, this workshop aspires to empower healthcare providers with the knowledge and tools necessary for rational drug treatment in the digital age.
Speaker
Prof Melissa Baysari
University of Sidney
The impact of drug-drug interaction alerts on drug-drug interactions and patient harms
Biography
Professor Melissa Baysari leads the Digital Health Human Factors Group at the University of Sydney, Australia. Her team apply human factors methods and approaches to evaluate and optimise health technologies to support healthcare work and improve patient safety. Melissa has published widely in the areas of medication safety, electronic medical record systems and decision support systems, and she has secured over AUD $30Mill in research funding. Importantly, Melissa’s research has resulted in a number of significant changes being made to clinical information systems, as well as to hospital policy and work practices, and her research has informed clinical decision support design guidelines both nationally and internationally.
Session chair
Ylva Bottiger
Lisa Kouladjian O'Donnell
University of Sydney
